First case of COVID-19 in a kidney transplant recipient treated with belatacept.
作者信息
Marx David, Moulin Bruno, Fafi-Kremer Samira, Benotmane Ilies, Gautier Gabriela, Perrin Peggy, Caillard Sophie
机构信息
Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Department of Virology, Strasbourg University Hospital, Strasbourg, France.
出版信息
Am J Transplant. 2020 Jul;20(7):1944-1946. doi: 10.1111/ajt.15919. Epub 2020 Apr 28.
Abstract
摘要
相似文献
1
First case of COVID-19 in a kidney transplant recipient treated with belatacept.
Am J Transplant. 2020 Jul;20(7):1944-1946. doi: 10.1111/ajt.15919. Epub 2020 Apr 28.
2
Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report.
Am J Transplant. 2020 Jul;20(7):1864-1868. doi: 10.1111/ajt.15897. Epub 2020 May 8.
3
COVID-19 in kidney transplant recipients.
Am J Transplant. 2020 Jul;20(7):1941-1943. doi: 10.1111/ajt.15891. Epub 2020 Apr 12.
4
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.
Am J Transplant. 2020 Jul;20(7):1859-1863. doi: 10.1111/ajt.15869. Epub 2020 Mar 31.
5
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
6
Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient.
Am J Transplant. 2020 Jul;20(7):1891-1895. doi: 10.1111/ajt.15901. Epub 2020 Apr 19.
7
SARS Cov-2 infection in a renal-transplanted patient: A case report.
Am J Transplant. 2020 Jul;20(7):1882-1884. doi: 10.1111/ajt.15902. Epub 2020 May 10.
8
Novel coronavirus 2019 pneumonia in a kidney transplant recipient.
Am J Transplant. 2020 Sep;20(9):2599-2601. doi: 10.1111/ajt.15999. Epub 2020 Jun 12.
9
COVID-19 in a high-risk dual heart and kidney transplant recipient.
Am J Transplant. 2020 Jul;20(7):1911-1915. doi: 10.1111/ajt.15936. Epub 2020 Jun 22.
10
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine.
Am J Transplant. 2020 Jul;20(7):1902-1906. doi: 10.1111/ajt.15935. Epub 2020 May 13.
引用本文的文献
1
Indications and complications associated with centrifuge-based therapeutic plasma exchange - a retrospective review.
BMC Nephrol. 2025 Feb 19;26(1):87. doi: 10.1186/s12882-025-03970-2.
2
A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation.
Transplantation. 2024 Mar 1;108(3):777-786. doi: 10.1097/TP.0000000000004841. Epub 2024 Feb 20.
3
[COVID-19 in transplant recipients: Multicentric report of Mexican experience].
Arch Cardiol Mex. 2023 Sep 5;93(Supl 6):66-74. doi: 10.24875/ACM.21000113.
4
Covid-19 in kidney transplant recipients with immunosuppressive therapy.
Caspian J Intern Med. 2022;13(Suppl 3):161-172. doi: 10.22088/cjim.12.4.509.
5
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients.
Transplant Direct. 2022 Feb 10;8(3):e1292. doi: 10.1097/TXD.0000000000001292. eCollection 2022 Mar.
6
The Role of HLA Antigens and Steroid Dose on the Course of COVID-19 of Patients After Kidney Transplantation.
Front Med (Lausanne). 2021 Nov 1;8:730156. doi: 10.3389/fmed.2021.730156. eCollection 2021.
7
Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response.
J Clin Med. 2021 Nov 3;10(21):5159. doi: 10.3390/jcm10215159.
8
Renal involvement in COVID-19: focus on kidney transplant sector.
Infection. 2021 Dec;49(6):1265-1275. doi: 10.1007/s15010-021-01706-6. Epub 2021 Oct 5.
9
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
10
Coronavirus disease 2019 outcomes in heart transplant recipients: a single-center case series.
J Med Case Rep. 2021 Sep 13;15(1):453. doi: 10.1186/s13256-021-03028-5.
本文引用的文献
1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
3
Opportunistic infections after conversion to belatacept in kidney transplantation.
Nephrol Dial Transplant. 2020 Feb 1;35(2):336-345. doi: 10.1093/ndt/gfz255.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
J Gen Virol. 2013 Dec;94(Pt 12):2679-2690. doi: 10.1099/vir.0.055533-0. Epub 2013 Sep 28.
Zotero 插件